Chemours Co CC
Chemours Co (CC) earns a Piotroski F-score of 4/9 (mixed financial health). It pays a dividend yielding 2.50% (safety: safe). FY2025 revenue was $5.8B at a -6.6% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.94 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-07-01 | Mizuho | Outperform (main) |
| 2026-05-21 | JP Morgan | Neutral (main) |
| 2026-05-11 | Morgan Stanley | Equal-Weight (main) |
| 2026-05-11 | RBC Capital | Outperform (main) |
| 2026-05-08 | UBS | Buy (main) |
| 2026-04-28 | Truist Securities | Buy (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CC | Chemours Co | 4/9 | — | — | +0.4% |
| HUN | Huntsman CORP | 2/9 | 1.92 | — | -5.8% |
| OLN | OLIN Corp | 4/9 | 1.62 | — | +3.7% |
| SOLS | Solstice Advanced Materials Inc. | 3/9 | — | 55.4 | +3.1% |
| FMC | FMC CORP | 2/9 | 1.38 | — | -18.3% |
| IOSP | INNOSPEC INC. | 3/9 | 7.54 | — | -3.7% |
| NGVT | Ingevity Corp | 6/9 | 2.97 | — | -2.7% |
About Chemours Co
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
FAQ
Is CC financially healthy?
Chemours Co's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does CC pay a dividend, and is it safe?
Yes. Chemours Co pays a dividend yielding about 2.50% with a -20.2% payout ratio, rated “safe” for safety.
How profitable is CC?
In FY2025, Chemours Co had a net margin of -6.6% and a return on equity of -153.8%.
Is CC overvalued or undervalued?
Chemours Co trades at about 33.1× trailing earnings — above its 10-year norm (10-year range 6.6×–660.5×, median 13.2×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for CC?
The average Wall-Street price target for Chemours Co is $25.44, about 67.0% above the recent price, from 9 analysts (consensus: buy).
Is CC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Chemours Co: a Piotroski F-score of 4/9, a dividend yield of 2.50%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.